Journal
JOURNAL OF CELL BIOLOGY
Volume 217, Issue 1, Pages 65-77Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201708092
Keywords
-
Categories
Funding
- Medical Research Council [MC-A652-5PZ00, MC_U120085810]
- Unity Biotechnology
- MRC [MC_U120085810] Funding Source: UKRI
Ask authors/readers for more resources
Aging is the major risk factor for cancer, cardiovascular disease, diabetes, and neurodegenerative disorders. Although we are far from understanding the biological basis of aging, research suggests that targeting the aging process itself could ameliorate many age-related pathologies. Senescence is a cellular response characterized by a stable growth arrest and other phenotypic alterations that include a proinflammatory secretome. Senescence plays roles in normal development, maintains tissue homeostasis, and limits tumor progression. However, senescence has also been implicated as a major cause of age-related disease. In this regard, recent experimental evidence has shown that the genetic or pharmacological ablation of senescent cells extends life span and improves health span. Here, we review the cellular and molecular links between cellular senescence and aging and discuss the novel therapeutic avenues that this connection opens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available